4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-21-041496
Director sold 5,000 shares at $19.42 ($97,122)
- Director acquired 4,015 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mitchell Stephen Ray Director | 2021-06-15 | Option exercise | +4,015 | $10.57 | $42,439 | 14,215 | D: show line 1 in the form |
| Mitchell Stephen Ray Director | 2021-06-15 | Sale | −5,000 | $19.42 | $97,122 | 9,215 | D: show line 2 in the form |
| Open-market sales · 5,000 sh · avg $19.42 · $97,122 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mitchell Stephen Ray Director | 2021-06-15 | Option exercise · Stock Option (right to buy) | −4,015 | 5,985 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…